Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Philippe Charron(Laboratoire National de Référence), Luigi Tavazzi(Cornell University), Andre Keren, Perry Elliott(UCL Australia), William J. McKenna, Lorenzo Monserrat(Universidade da Coruña), Claudio Rapezzi(Boston University), Irene M. van Langen, Michael Arad(Tel Aviv University), Zofia T. Bilińska, Sabine Pankuweit(Universitätsklinikum Gießen und Marburg), Andreas Perrot(Max Delbrück Center), Hubert Seggewiß(Leopoldina Krankenhaus Schweinfurt), Cristina Basso(University of Padua), Tiina Heliö(Helsinki University Hospital), Arsen Ristić, Eloisa Arbustini
Cited by 485
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
|Circulation|1996|3.5k
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
|Circulation|2010|2.7k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k